Goserelin Depot
Hormone‑Dependent Breast and Prostate Cancer
PreclinicalActive
Key Facts
Indication
Hormone‑Dependent Breast and Prostate Cancer
Phase
Preclinical
Status
Active
Company
About Nanox Release Technology
Nanox creates nanocarrier formulations to enhance delivery of oncology and infectious disease drugs.
View full company profile